title: Imatinib-induced eccrine squamous syringometaplasia.
authors.forename: Karen
authors.initials: K
authors.lastname: Van de Voorde
authors.forename: Hendrik
authors.initials: H
authors.lastname: De Raeve
authors.forename: Niels
authors.initials: N
authors.lastname: Van Regenmortel
authors.forename: Julien
authors.initials: J
authors.lastname: Lambert
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D003875:Drug Eruptions / Q000473:pathology*; D004439:Eccrine Glands / Q000473:pathology*; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D008679:Metaplasia; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*; D013543:Sweat Gland Diseases / Q000139:chemically induced* / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate